XBI

SPDR S&P Biotech ETF

$77.12
$0.00
(0%)
As of 9:10:00 AM EDT | 10/14/19  |  Market Open

XBI Trading Data

Open

$77.12

Low Price

$77.12

High Price

$77.12

Previous Last Price

$77.12

Bid Size

$77.01 X 200

Ask Size

$77.26 X 300

XBI Portfolio Data

AUM

$3,422,700,000

Shares

45,000

PE Ratio

17.55

Price / Book Ratio

4.35

Expense Ratio

0.35

Net Asset Value

$76.06

Volume

Volume

7,790

Avg. Volume (YDT)

4,717,716

Dollar Volume

$205,890,419

Weekly Avg. Volume

4,547,018

Monthly Avg. Volume

5,672,084

Quarterly Avg. Volume

4,536,627

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Seattle Genetics Inc. (SGEN)
2%
Medicines Company (MDCO)
1.9%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.85%
Regeneron Pharmaceuticals Inc. (REGN)
1.83%
AbbVie Inc. (ABBV)
1.83%
Ligand Pharmaceuticals Incorporated (LGND)
1.83%
Amgen Inc. (AMGN)
1.76%
Celgene Corporation (CELG)
1.75%
United Therapeutics Corporation (UTHR)
1.73%
Incyte Corporation (INCY)
1.72%

Total XBI Holdings

Total Holdings: 121

Seattle Genetics Inc. (SGEN)
2%
Medicines Company (MDCO)
1.9%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.85%
Regeneron Pharmaceuticals Inc. (REGN)
1.83%
AbbVie Inc. (ABBV)
1.83%
Ligand Pharmaceuticals Incorporated (LGND)
1.83%
Amgen Inc. (AMGN)
1.76%
Celgene Corporation (CELG)
1.75%
United Therapeutics Corporation (UTHR)
1.73%
Incyte Corporation (INCY)
1.72%
Vertex Pharmaceuticals Incorporated (VRTX)
1.68%
Sarepta Therapeutics Inc. (SRPT)
1.67%
Repligen Corporation (RGEN)
1.65%
Gilead Sciences Inc. (GILD)
1.64%
Biogen Inc. (BIIB)
1.63%
Ionis Pharmaceuticals Inc. (IONS)
1.62%
Alnylam Pharmaceuticals Inc (ALNY)
1.6%
Spark Therapeutics Inc. (ONCE)
1.59%
Neurocrine Biosciences Inc. (NBIX)
1.59%
Alexion Pharmaceuticals Inc. (ALXN)
1.58%
BioMarin Pharmaceutical Inc. (BMRN)
1.58%
Blueprint Medicines Corp. (BPMC)
1.58%
Mirati Therapeutics Inc. (MRTX)
1.53%
Exelixis Inc. (EXEL)
1.49%
Invitae Corp. (NVTA)
1.48%
Intercept Pharmaceuticals Inc. (ICPT)
1.48%
bluebird bio Inc. (BLUE)
1.47%
SAGE Therapeutics Inc. (SAGE)
1.47%
Global Blood Therapeutics Inc (GBT)
1.47%
Exact Sciences Corporation (EXAS)
1.47%
CareDx Inc. (CDNA)
1.46%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
1.4%
ACADIA Pharmaceuticals Inc. (ACAD)
1.34%
Amicus Therapeutics Inc. (FOLD)
1.32%
Genomic Health Inc. (GHDX)
1.29%
Arena Pharmaceuticals Inc. (ARNA)
1.24%
FibroGen Inc. (FGEN)
1.23%
REGENXBIO Inc. (RGNX)
1.22%
Ra Pharmaceuticals Inc. (RARX)
1.2%
Portola Pharmaceuticals Inc. (PTLA)
1.18%
Iovance Biotherapeutics Inc (IOVA)
1.17%
Immunomedics Inc. (IMMU)
1.14%
Ultragenyx Pharmaceutical Inc. (RARE)
1.11%
Myriad Genetics Inc. (MYGN)
1.1%
Alkermes Plc (ALKS)
1.01%
Agios Pharmaceuticals Inc. (AGIO)
0.99%
Insmed Incorporated (INSM)
0.99%
ArQule Inc. (ARQL)
0.94%
Esperion Therapeutics Inc. (ESPR)
0.94%
Natera Inc. (NTRA)
0.9%
PTC Therapeutics Inc. (PTCT)
0.83%
Madrigal Pharmaceuticals Inc. (MDGL)
0.79%
Veracyte Inc (VCYT)
0.78%
Coherus BioSciences Inc. (CHRS)
0.78%
Emergent BioSolutions Inc. (EBS)
0.77%
Alder Biopharmaceuticals Inc. (ALDR)
0.73%
Xencor Inc. (XNCR)
0.71%
Allakos Inc. (ALLK)
0.67%
Halozyme Therapeutics Inc. (HALO)
0.66%
Enanta Pharmaceuticals Inc. (ENTA)
0.64%
Audentes Therapeutics Inc. (BOLD)
0.61%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.61%
Editas Medicine Inc. (EDIT)
0.6%
Fate Therapeutics Inc. (FATE)
0.58%
Sangamo Therapeutics Inc. (SGMO)
0.58%
Atara Biotherapeutics Inc (ATRA)
0.58%
Heron Therapeutics Inc (HRTX)
0.56%
AnaptysBio Inc. (ANAB)
0.56%
Aimmune Therapeutics Inc (AIMT)
0.54%
Karyopharm Therapeutics Inc. (KPTI)
0.53%
Adverum Biotechnologies Inc (ADVM)
0.52%
Acceleron Pharma Inc (XLRN)
0.52%
Vanda Pharmaceuticals Inc. (VNDA)
0.47%
Puma Biotechnology Inc. (PBYI)
0.45%
Intrexon Corporation (XON)
0.45%
Viking Therapeutics Inc. (VKTX)
0.44%
ZIOPHARM Oncology Inc. (ZIOP)
0.44%
Athenex Inc. (ATNX)
0.43%
Allogene Therapeutics Inc. (ALLO)
0.41%
Radius Health Inc (RDUS)
0.4%
Apellis Pharmaceuticals Inc. (APLS)
0.4%
AMAG Pharmaceuticals Inc. (AMAG)
0.39%
Eagle Pharmaceuticals Inc. (EGRX)
0.39%
Retrophin Inc. (RTRX)
0.39%
Vericel Corporation (VCEL)
0.38%
Voyager Therapeutics Inc. (VYGR)
0.37%
Anika Therapeutics Inc. (ANIK)
0.36%
Epizyme Inc. (EPZM)
0.35%
Deciphera Pharmaceuticals Inc. (DCPH)
0.35%
OPKO Health Inc. (OPK)
0.34%
TG Therapeutics Inc. (TGTX)
0.32%
Intellia Therapeutics Inc. (NTLA)
0.3%
G1 Therapeutics Inc. (GTHX)
0.29%
MacroGenics Inc. (MGNX)
0.28%
Flexion Therapeutics Inc. (FLXN)
0.28%
Dicerna Pharmaceuticals Inc. (DRNA)
0.28%
Stemline Therapeutics Inc. (STML)
0.27%
Twist Bioscience Corp. (TWST)
0.27%
Momenta Pharmaceuticals Inc. (MNTA)
0.27%
Krystal Biotech Inc. (KRYS)
0.26%
Turning Point Therapeutics Inc. (TPTX)
0.25%
Spectrum Pharmaceuticals Inc. (SPPI)
0.24%
Denali Therapeutics Inc. (DNLI)
0.23%
Cytokinetics Incorporated (CYTK)
0.21%
Kura Oncology Inc. (KURA)
0.21%
Catalyst Pharmaceuticals Inc. (CPRX)
0.21%
ImmunoGen Inc. (IMGN)
0.2%
Akcea Therapeutics Inc. (AKCA)
0.19%
Progenics Pharmaceuticals Inc. (PGNX)
0.18%
BioCryst Pharmaceuticals Inc. (BCRX)
0.17%
Achillion Pharmaceuticals Inc. (ACHN)
0.17%
Rhythm Pharmaceuticals Inc. (RYTM)
0.16%
Akebia Therapeutics Inc. (AKBA)
0.15%
Homology Medicines Inc. (FIXX)
0.14%
Rocket Pharmaceuticals Inc. (RCKT)
0.13%
CytomX Therapeutics Inc. (CTMX)
0.12%
AVROBIO Inc (AVRO)
0.11%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.1%
Prothena Corp. Plc (PRTA)
0.08%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

-0.98

Beta

1.67

Leverage

Long

Standard Deviation

5.57

XBI Dividends

Dividend Date

2019-09-20

Latest Dividend

0.003

Annual Dividend

0.02

Annual Dividend Rate

0.02

Annual Dividend Yield

0.02

XBI Performance

YTD Return

7.48%

1 Year Return

-10.43%

3 Year Return

29.48%

5 Year Return

48.23%

10 Year Return

395.74%

XBI Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.